Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells

Meier P.J., Stieger B. (2002) Bile salt transporters. Annu. Rev. Physiol. 64:635–661 Yabuuchi H., Tamai I., Morita K., Kouda T., Miyamoto K., Takeda E., Tsuji A. (1998) Hepatic sinusoidal membrane transport of anionic drugs mediated by anion transporter Npt1. J. Pharmacol. Exp. Ther. 286:1391–1396 Kullak-Ublick G.A., Hagenbuch B., Stieger B., Schteingart C.D., Hofmann A.F., Wolkoff A.W., Meier P.J. (1995) Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109:1274–1282 Suzuki H., Sugiyama Y. (2000) Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver. Semin. Liver. Dis. 20:251–263 Abe T., Kakyo M., Tokui T., Nakagomi R., Nishio T., Nakai D., Nomura H., Unno M., Suzuki M., Naitoh T., Matsuno S., Yawo H. (1999) Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J. Biol. Chem. 274:17159–17163 Abe T., Kakyo M., Sakagami H., Tokui T., Nishio T., Tanemoto M., Nomura H., Hebert S.C., Matsuno S., Kondo H., Yawo H. (1998) Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with OATP-C. J. Biol. Chem. 273:22395–22401 Bossuyt X., Muller M., Meier P.J. (1996) Multispecific amphipathic substrate transport by an organic anion transporter of human liver. J. Hepatol. 25:733–738 Tamai I., Nezu J., Uchino H., Sai Y., Oku A., Shimane M., Tsuji A. (2000) Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273:251–260 Tamai I., Nozawa T., Koshida M., Nezu J., Sai Y., Tsuji A. (2001) Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm. Res. 18:1262–1269 Tirona R.G., Leake B.F., Wolkoff A.W., Kim R.B. (2003) Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J. Pharmacol. Exp. Ther. 304:223–228 Cui Y., Konig J., Leier I., Buchholz U., Keppler D. (2001) Hepatic uptake of bilirubin and its conjugated by the human organic anion transporter SLC21A6. J. Biol. Chem. 276:9626-9630 Nordstrom D.K. (2002) Worldwide occurrences of arsenic in ground water. Science 296:2143–2145 Smith A.H., Lopipero P.A., Bates M.N., Steinmaus C.M. (2002) Arsenic epidemiology and drinking water standards. Science 296:2145–2146 Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. (1985) Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 45:5895–5899 Leonard A., Lauwerys R.R. (1980) Carcinogenicity, teratogenicity and mutagenicity of arsenic. Mutat. Res. 75:49–62 Pinto S.S., Nelson K.W. (1976) Arsenic toxicology and industrial exposure. Annu. Rev. Pharmacol. Toxicol. 16:95–100 Niu C., Yan H., Yu T., Sun H.P., Liu J.X., Li X.S., Wu W., Zhang F.Q., Chen Y., Zhou L., Li J.M., Zeng X.Y., Ou Yang R.R., Yuan M.M., Ren M.Y., Gu F.Y., Cao Q., Gu B.W., Su X.Y., Chen G.Q., Xiong S.M., Zhang T.D., Waxman S., Wang Z.Y., Chen Z., Hu J., Shen Z.X., Chen S.J. (1999) Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94:3315–3324 Soignet S., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrell Jr R.P. (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Engl. J. Med. 339:1341–1348 Fischer A.B., Buchet J.P., Lauwerys R.R. (1985) Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 57:168–172 Moore M.M., Harring-Brock K., Doerr C.L. (1997) Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:279–290 Sakurai T., Kaisc T., Matsubara C. (1998) Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol. 11:273–283 Buchet J.P., Lauwerys R., Roels H. (1981) Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinite in man. Int. Arch. Occup. Environ. Health. 48:71–79 Carlin A., Shi W., Dey S., Rosen B.P. (1995) The ars operon of Escherichia coli confers arsenical and antimonial resistance. J. Bacteriol. 177:981–986 Ji G., Silver S. (1992) Reduction of arsenate to arsenite by the ArsC protein of the arsenic resistance operon of Staphylococcus aureus plasmid pI258. Proc. Natl. Acad. Sci. USA 89:9474–9478 Zaman G.J., Lankelma J., van Tellingen O., Beijnen J., Dekker H., Paulusma C., Oude Elferink R.P., Baas F., Borst P. (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. U. S. A. 92:7690–7694 Leslie E.M., Haimeur A., Waalkes M.P. (2004) Arsenic transport by human multidrug resistance protein 1 (MRP1/ABCC1). J. Biol. Chem. 279:32700–32708 Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W. (2000) Rice J.S., Lieberman M.W., The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:33404–33408 Liu Z., Shen J., Carbrey J.M., Mukhopadhyay R., Agre P., Rosen B.P. (2002) Arsenite transport by mammalian aquagoyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. U. S. A. 99:6053–6058 Liu Z., Carbrey J.M., Agre P., Rosen B.P. (2004) Arsenic trioxide uptake by human and rat aquaglyceroporins. Biochem. Biophys. Res. Commun. 316:1178–1185 Zalups R.K., Barfuss D.W. (2002) Renal organic anion transport system: a mechanism for the basolsteral uptake of mercury–thiol conjugates along the pars recta of the proximal tubule. Toxicol. Appl. Pharmacol. 182:234–243 Li L., Lee T.K., Meier P.J., Ballatori N. (1998) Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J. Biol. Chem. 273:16184–16191 Li L., Lee T.K., Meier P.J., Ballatori N. (2000) Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol. Pharmacol. 58:335–340 Cui Y., Konig J., Leier I., Buchholz U., Spring H., Keppler D. (1999) Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55:929–937 Cui Y., Konig J., Nies A.T., Pfannschmidt M., Hergt M., Franke W., Alt W., Moll R., Keppler D. (2003) Detection of the human organic anion transporters SLC21A6 (OATP-C) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab. Invest. 83:527–538 Eguchi N., Kuroda K., Endo G. (1997) Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch. Environ. Contam. Toxicol. 32:141–145 Ochi T., Kaise T., Oya Ohta Y. (1994) Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells. Experientia 50:115–120 Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:289–299 Nemeti B., Gregus Z. (2002) Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70:4–12 Scott N., Hatlelid K.M., Mackenzie N.E., Carter D.E. (1993) Reactions of arsenic (III) and arsenic (V) species with glutathione. Chem. Res. Toxicol. 6:102–106 Delnomdedieu M., Basti M.M., Otvos J.D., Thomas D.J. (1994) Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem. Biol. Interact. 90:139–155 Hung R.N., Lee T.C. (1996) Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol. Appl. Pharmacol. 136:243–249